Patented by Genoks Genetic Diseases Evaluation Center, RapidNIPT is reported within 3 working days. In some cases this period can extend up to 5 working days.
The baby's sex is usually determined between weeks 16 and 20 of pregnancy through ultrasound, with blood tests and genetic tests offering earlier insights.
RapidNIPT screens for over 90 genetic conditions, including Down syndrome, using cfDNA analysis. It is a non-invasive NIPT test that poses no risk to the mother or the baby and offers a high level of accuracy.